Alignment Healthcare Inc(ALHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 6:26 PM ET (Korea 9/12 07:26)
Full metrics table
| Index | RUT | P/E | 67.43 | EPS (ttm) | 0.19 | Insider Own | 4.75% | Shs Outstand | 207.2M | Perf Week | -7.05% |
| Market Cap | 2.61B | Forward P/E | 29.15 | EPS next Y | 139.06% | Insider Trans | -20.85% | Shs Float | 197.6M | Perf Month | -6.88% |
| Enterprise Value | - | PEG | - | EPS next Q | -0.01 | Inst Own | 114.18% | Short Float | 11.56% | Perf Quarter | -37.8% |
| Income | 0.04B | P/S | 0.57 | EPS this Y | - | Inst Trans | 10.85% | Short Ratio | 4.49 | Perf Half Y | -26.46% |
| Sales | 4.58B | P/B | 9.84 | EPS next 5Y | - | ROA | 3.57% | Short Interest | 22.84M | Perf YTD | -36.25% |
| Book/sh | 1.28 | P/C | - | EPS past 3/5Y | 83.51% 50.33% | ROE | 20.04% | 52W High | -49.88% ($25.12) | Perf Year | -23% |
| Cash/sh | - | P/FCF | 14.71 | Sales past 3/5Y | 40.16% 32.71% | ROIC | 6.83% | 52W Low | -0.47% ($12.65) | Perf 3Y | 138% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 173.03% | Gross Margin | - | Volatility(W/M) | 4.36% 4.11% | Perf 5Y | -32.89% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | 37.21% | Oper. Margin | 1.2% | ATR (14) | 0.68 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | 127.27% | Profit Margin | 0.89% | RSI (14) | 31.17 | Recom | 1.43 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.7 | Sales Q/Q | 31.55% | SMA20 | -5.74% ($13.36) | Beta | 1.1 | Target Price | $24.08 |
| Payout | - | Debt/Eq | 1.25 | Earnings | 2026/7/30 | SMA50 | -23.11% ($16.37) | Rel Volume | 1.19 | Prev Close | $12.76 |
| Employees | 1849 | LT Debt/Eq | 1.25 | EPS/Sales Surpr. | 31.78% 1.96% | SMA200 | -33.08% ($18.81) | Avg Volume(3M) | 5.09M | Price | $12.59 |
| IPO | 2021/3/26 | Option/Short | Yes/Yes | Trades | 31410 | Volume | 6,075,348 | Change | -1.33% |
Company
ALHC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A U.S. health insurance company that provides Medicare Advantage plans. It operates technology-driven Medicare Advantage insurance plans for seniors, offering exposure to subscriber growth and medical management. The company is a player in the technology-based Medicare Advantage space.
Over the past 1 year, on the lower side
50% below its 1-year high.
ALHC makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +139.1% this year.
Tap to view numbers
But it is not cheap
Trading at 67.4 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +138.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 114.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HEAL 0.03%
ASCE 0.02%
CPAI 0.02%
LGHT 0.02%
XHS 0.02%It ranks #4 in the industry
Based on market cap of $3B.
ALHC $3B PER 67.4
UNH $340B PER 24.4
CVS $121B PER 25.0
ELV $91B PER 18.6
FAQ
What kind of company is ALHC?
ALHC belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of ALHC?
The market cap of ALHC is approximately $2.6B, ranking 1,899 within its sector.
What is the P/E ratio of ALHC?
ALHC has a P/E ratio of approximately 67.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ALHC?
ALHC has recorded a 52-week high of $25.12 and a low of $12.65.
